- Home
- LESL vs CLNN Comparison
LESL vs CLNN Comparison
Compare LESL & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LESL
- CLNN
- Stock Information
- Founded
- LESL 1963
- CLNN 2012
- Country
- LESL United States
- CLNN United States
- Employees
- LESL N/A
- CLNN N/A
- Industry
- LESL Diversified Commercial Services
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- LESL Miscellaneous
- CLNN Health Care
- Exchange
- LESL Nasdaq
- CLNN Nasdaq
- Market Cap
- LESL 66.9M
- CLNN 60.3M
- IPO Year
- LESL 2020
- CLNN N/A
- Fundamental
- Price
- LESL $3.52
- CLNN $12.50
- Analyst Decision
- LESL Hold
- CLNN Strong Buy
- Analyst Count
- LESL 9
- CLNN 6
- Target Price
- LESL $33.25
- CLNN $32.67
- AVG Volume (30 Days)
- LESL 159.1K
- CLNN 138.6K
- Earning Date
- LESL 11-24-2025
- CLNN 11-07-2025
- Dividend Yield
- LESL N/A
- CLNN N/A
- EPS Growth
- LESL N/A
- CLNN N/A
- EPS
- LESL N/A
- CLNN N/A
- Revenue
- LESL $1,250,568,000.00
- CLNN $286,000.00
- Revenue This Year
- LESL N/A
- CLNN N/A
- Revenue Next Year
- LESL N/A
- CLNN $1,363.77
- P/E Ratio
- LESL N/A
- CLNN N/A
- Revenue Growth
- LESL N/A
- CLNN N/A
- 52 Week Low
- LESL $3.50
- CLNN $2.28
- 52 Week High
- LESL $72.60
- CLNN $12.75
- Technical
- Relative Strength Index (RSI)
- LESL 49.72
- CLNN 75.21
- Support Level
- LESL $3.54
- CLNN $7.66
- Resistance Level
- LESL $4.52
- CLNN $9.77
- Average True Range (ATR)
- LESL 0.37
- CLNN 0.99
- MACD
- LESL -0.20
- CLNN 0.21
- Stochastic Oscillator
- LESL 1.83
- CLNN 95.10
About LESL Leslie's Inc.
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.